# The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

> clinical trial · VERIFIED · 2026-07-27

Status: RECRUITING · Sponsor: phenox Inc. · Condition: Hemorrhagic Stroke

- Company: phenox Inc.
- Sector: medical devices
- Primary source: https://clinicaltrials.gov/study/NCT07143019

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.